Table 4 Baseline LDL cholesterol levels modelled as 'untreated' (see text for methods)
From: Patterns and predictors of statin prescription in patients with type 2 diabetes
LDL cholesterol (mg/dl) | Primary prevention | Secondary prevention | ||||
|---|---|---|---|---|---|---|
Percent statin use | Odds ratio (95% CI) | P-value | Percent statin use (%) | Odds ratio (95% CI) | P-value | |
<100 | 12.6% (11.4 to 13.9) | referent | 39.0% (36.9 to 41.2) | referent | ||
≥100 and <130 | 14.8% (14.0 to 15.7) | 1.20 (1.06 to 1.37) | 0.005 | 38.2% (36.6 to 39.7) | 0.97 (0.87 to 1.08) | 0.54 |
≥130 and <160 | 16.2% (15.4 to 17.1) | 1.34 (1.18 to 1.52) | <0.0001 | 34.4% (32.9 to 35.8) | 0.82 (0.74 to 0.92) | 0.0004 |
≥160 | 28.5% (27.5 to 29.5) | 2.76 (2.45 to 3.11) | <0.0001 | 43.3% (41.9 to 44.7) | 1.20 (1.08 to 1.33) | 0.0009 |